Iterum Therapeutics plc
(NASDAQ: ITRM)

Iterum Therapeutics Plc operates as a pharmaceutical company, which engages in the development and commercialization of sulopenem. The company was founded by Corey N. Fishman on June 24, 2015 and is headquartered in Dublin, Ireland.

0.173 -

+0.002 (+1.17%)
Range 0.167 - 0.177   (5.99%)
Open 0.177
Previous Close 0.171
Bid Price -
Bid Volume -
Ask Price -
Ask Volume -
Volume 488,620
Value 46,578
Remark -
Delayed prices. Updated at 14 Mar 2026 08:15.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis